Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
18.09
-0.04 (-0.22%)
At close: Sep 16, 2025, 4:00 PM EDT
18.30
+0.21 (1.16%)
After-hours: Sep 16, 2025, 7:11 PM EDT
ARCT Employees
As of December 31, 2024, Arcturus Therapeutics Holdings had 176 total employees, including 174 full-time and 2 part-time employees. The number of employees decreased by 4 or -2.22% compared to the previous year.
Employees
176
Change (1Y)
-4
Growth (1Y)
-2.22%
Revenue / Employee
$693,875
Profits / Employee
-$341,841
Market Cap
491.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176 | -4 | -2.22% |
| Dec 31, 2023 | 180 | 10 | 5.88% |
| Dec 31, 2022 | 170 | -7 | -3.95% |
| Dec 31, 2021 | 177 | 59 | 50.00% |
| Dec 31, 2020 | 118 | 30 | 34.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARCT News
- 21 days ago - Arcturus Therapeutics to Attend Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 5 weeks ago - Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress - Business Wire
- 7 weeks ago - Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - Business Wire
- 2 months ago - Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program - Business Wire
- 3 months ago - Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency - Business Wire
- 4 months ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress - Business Wire